{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:58:07Z","timestamp":1790456287628,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06241-9","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:45:54Z","timestamp":1790408754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Symptomatic Rescue or Disease Modification? A Critical Review of Levodopa and Phytochemical Interventions in Caenorhabditis elegans Models of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9422-3402","authenticated-orcid":false,"given":"Emre","family":"Akta\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4687-0223","authenticated-orcid":false,"given":"\u015eeyda","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"6241_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397:2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"key":"6241_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70124","volume":"169","author":"MS Ho","year":"2025","unstructured":"Ho MS (2025) Clearance pathways for \u03b1-synuclein in Parkinson\u2019s disease. J Neurochem 169:e70124. https:\/\/doi.org\/10.1111\/jnc.70124","journal-title":"J Neurochem"},{"key":"6241_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70656","volume":"40","author":"NK Singh","year":"2026","unstructured":"Singh NK, Solanki K (2026) Unveiling the potential of flavonoids in the regulation of Parkinson\u2019s disease: special focus on quercetin. J Biochem Mol Toxicol 40:e70656. https:\/\/doi.org\/10.1002\/jbt.70656","journal-title":"J Biochem Mol Toxicol"},{"key":"6241_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","volume":"10","author":"X Xu","year":"2025","unstructured":"Xu X, Pang Y, Fan X (2025) Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Sig Transduct Target Ther 10:190. https:\/\/doi.org\/10.1038\/s41392-025-02253-4","journal-title":"Sig Transduct Target Ther"},{"key":"6241_CR5","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.3390\/ijms27062742","volume":"27","author":"M D\u0119biec","year":"2026","unstructured":"D\u0119biec M, Rojek M (2026) Adult neurogenesis in neurodegenerative diseases: mechanisms of dysregulation in Alzheimer\u2019s and Parkinson\u2019s disease. Int J Mol Sci 27:2742. https:\/\/doi.org\/10.3390\/ijms27062742","journal-title":"Int J Mol Sci"},{"key":"6241_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00702-025-02893-4","volume":"132","author":"P Riederer","year":"2025","unstructured":"Riederer P, Strobel S, Nagatsu T et al (2025) Levodopa treatment: impacts and mechanisms throughout Parkinson\u2019s disease progression. J Neural Transm 132:743\u2013779. https:\/\/doi.org\/10.1007\/s00702-025-02893-4","journal-title":"J Neural Transm"},{"key":"6241_CR7","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1007\/s11010-025-05324-w","volume":"480","author":"SR Kulkarni","year":"2025","unstructured":"Kulkarni SR, Thokchom B, Abbigeri MB et al (2025) The role of L-DOPA in neurological and neurodegenerative complications: a review. Mol Cell Biochem 480:5221\u20135242. https:\/\/doi.org\/10.1007\/s11010-025-05324-w","journal-title":"Mol Cell Biochem"},{"key":"6241_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S1474-4422(24)00116-9","volume":"23","author":"F Cardoso","year":"2024","unstructured":"Cardoso F, Tolosa E (2024) Fluctuations in Parkinson\u2019s disease: progress and challenges. Lancet Neurol 23:448\u2013449. https:\/\/doi.org\/10.1016\/S1474-4422(24)00116-9","journal-title":"Lancet Neurol"},{"key":"6241_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1692592","author":"A Reinares-Sebasti\u00e1n","year":"2025","unstructured":"Reinares-Sebasti\u00e1n A, Esteban-Garc\u00eda N, Takada M, Trigo-Damas I (2025) Drug discovery and development for Parkinson\u2019s disease: are preclinical models good enough? Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2025.1692592","journal-title":"Front Aging Neurosci"},{"key":"6241_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1248727","author":"C Sanfeliu","year":"2024","unstructured":"Sanfeliu C, Bartra C, Su\u00f1ol C, Rodr\u00edguez-Farr\u00e9 E (2024) New insights in animal models of neurotoxicity-induced neurodegeneration. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2023.1248727","journal-title":"Front Neurosci"},{"key":"6241_CR11","unstructured":"Hassinan C (2025) The Development of Rhythmic Behavior. Ph.D"},{"key":"6241_CR12","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.250843","volume":"12","author":"I Muralidhara","year":"2025","unstructured":"Muralidhara I, Hardege I (2025) The dopaminergic system of Caenorhabditis elegans. R Soc Open Sci 12:250843. https:\/\/doi.org\/10.1098\/rsos.250843","journal-title":"R Soc Open Sci"},{"key":"6241_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1535682","author":"VK Yadav","year":"2025","unstructured":"Yadav VK, Dhanasekaran S, Choudhary N et al (2025) Recent advances in nanotechnology for Parkinson\u2019s disease: diagnosis, treatment, and future perspectives. Front Med. https:\/\/doi.org\/10.3389\/fmed.2025.1535682","journal-title":"Front Med"},{"key":"6241_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","volume":"12","author":"A Dovonou","year":"2023","unstructured":"Dovonou A, Bolduc C, Soto Linan V et al (2023) Animal models of Parkinson\u2019s disease: bridging the gap between disease hallmarks and research questions. Transl Neurodegener 12:36. https:\/\/doi.org\/10.1186\/s40035-023-00368-8","journal-title":"Transl Neurodegener"},{"key":"6241_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1559151","volume":"19","author":"AK Torres","year":"2025","unstructured":"Torres AK, Mira RG, Pinto C, Inestrosa NC (2025) Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunities. Front Cell Neurosci 19:1559151. https:\/\/doi.org\/10.3389\/fncel.2025.1559151","journal-title":"Front Cell Neurosci"},{"key":"6241_CR16","first-page":"1","volume-title":"Parkinsonism and the environment","author":"ML Machado","year":"2022","unstructured":"Machado ML, Zamberlan DC, Arantes LP et al (2022) The use and predictability of C. elegans as an alternative and complementary model in neurotoxicological studies: focus on the dopaminergic system. In: Filipov NM (ed) Parkinsonism and the environment. Springer International Publishing, Cham, pp 1\u201318"},{"key":"6241_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2024.1374866","author":"I Lee","year":"2024","unstructured":"Lee I, Knickerbocker AC, Depew CR et al (2024) Effect of altered production and storage of dopamine on development and behavior in C. elegans. Front Toxicol. https:\/\/doi.org\/10.3389\/ftox.2024.1374866","journal-title":"Front Toxicol"},{"key":"6241_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-024-00686-3","volume":"42","author":"LPD da Silva","year":"2024","unstructured":"da Silva LPD, da Cruz Guedes E, Fernandes ICO et al (2024) Exploring Caenorhabditis elegans as Parkinson\u2019s disease model: neurotoxins and genetic implications. Neurotox Res 42:11. https:\/\/doi.org\/10.1007\/s12640-024-00686-3","journal-title":"Neurotox Res"},{"key":"6241_CR19","doi-asserted-by":"publisher","first-page":"32339","DOI":"10.1021\/acsomega.2c03384","volume":"7","author":"ACV de Guzman","year":"2022","unstructured":"de Guzman ACV, Kang S, Kim EJ et al (2022) High-glucose diet attenuates the dopaminergic neuronal function in C. elegans, leading to the acceleration of the aging process. ACS Omega 7:32339\u201332348. https:\/\/doi.org\/10.1021\/acsomega.2c03384","journal-title":"ACS Omega"},{"key":"6241_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/ph15050512","volume":"15","author":"S Hughes","year":"2022","unstructured":"Hughes S, Van Dop M, Kolsters N et al (2022) Using a Caenorhabditis elegans Parkinson\u2019s disease model to assess disease progression and therapy efficiency. Pharmaceuticals 15:512. https:\/\/doi.org\/10.3390\/ph15050512","journal-title":"Pharmaceuticals"},{"key":"6241_CR21","unstructured":"(2024) Using C. elegans as a model for neurodegenerative diseases: methodology and evaluation. In: Methods in Cell Biology. Academic Press, pp 1\u201334"},{"key":"6241_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1624593","author":"E Khan","year":"2025","unstructured":"Khan E, Radwan N, Ardah MT et al (2025) Rotenone accelerates endogenous \u03b1-synuclein spreading and enhances neurodegeneration in an intra-striatal \u03b1-synuclein preformed fibril injected mouse model of Parkinson\u2019s disease. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2025.1624593","journal-title":"Front Cell Neurosci"},{"key":"6241_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70401","volume":"31","author":"A Balkrishna","year":"2025","unstructured":"Balkrishna A, Pathak N, Singh R et al (2025) Neurogrit gold attenuates 6-OHDA-induced dopaminergic neurodegeneration in Parkinson\u2019s model of Caenorhabditis elegans by reducing \u03b1-synuclein accumulation and Pink\/Pdr-1 driven mitochondrial dysfunction. CNS Neurosci Ther 31:e70401. https:\/\/doi.org\/10.1111\/cns.70401","journal-title":"CNS Neurosci Ther"},{"key":"6241_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/978-981-97-2859-6_12","volume-title":"Application of nanocarriers in brain delivery of therapeutics","author":"SV Mangrulkar","year":"2024","unstructured":"Mangrulkar SV, Dabhekar SV, Neje P et al (2024) In vivo animal models development and their limitations for brain research. In: Alexander A (ed) Application of nanocarriers in brain delivery of therapeutics. Springer Nature, Singapore, pp 315\u2013339"},{"key":"6241_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.916118","author":"FJ Naranjo-Galindo","year":"2022","unstructured":"Naranjo-Galindo FJ, Ai R, Fang EF et al (2022) C. elegans as an animal model to study the intersection of DNA repair, aging and neurodegeneration. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fragi.2022.916118","journal-title":"Front Aging Neurosci"},{"key":"6241_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/17460441.2024.2329103","volume":"19","author":"S Romussi","year":"2024","unstructured":"Romussi S, Giunti S, Andersen N, De Rosa MJ (2024) C. elegans: a prominent platform for modeling and drug screening in neurological disorders. Expert Opin Drug Discov 19:565\u2013585. https:\/\/doi.org\/10.1080\/17460441.2024.2329103","journal-title":"Expert Opin Drug Discov"},{"key":"6241_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.908696","author":"N Andersen","year":"2022","unstructured":"Andersen N, Veuthey T, Blanco MG et al (2022) 1-Mesityl-3-(3-sulfonatopropyl) imidazolium protects against oxidative stress and delays proteotoxicity in C. elegans. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.908696","journal-title":"Front Pharmacol"},{"key":"6241_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ijbiomac.2022.05.045","volume":"211","author":"W Wang","year":"2022","unstructured":"Wang W, Wang X, Gao W et al (2022) Ulvan inhibits \u03b1-synuclein fibrillation and disrupts the mature fibrils: in vitro and in vivo studies. Int J Biol Macromol 211:580\u2013591. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.05.045","journal-title":"Int J Biol Macromol"},{"key":"6241_CR29","unstructured":"Dunn R (2025) Internalized distributed motor commands bridge action and cognition in C. elegans. Ph.D"},{"key":"6241_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.21500\/20112084.6487","volume":"16","author":"D Becerra","year":"2023","unstructured":"Becerra D, Calixto A, Orio P (2023) The conscious nematode: exploring hallmarks of minimal phenomenal consciousness in Caenorhabditis elegans. Int J Psychol Res 16:87\u2013104. https:\/\/doi.org\/10.21500\/20112084.6487","journal-title":"Int J Psychol Res"},{"key":"6241_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14103","volume":"23","author":"TY Chen","year":"2024","unstructured":"Chen TY, Wang F-Y, Lee P-J et al (2024) Mitochondrial S-adenosylmethionine deficiency induces mitochondrial unfolded protein response and extends lifespan in Caenorhabditis elegans. Aging Cell 23:e14103. https:\/\/doi.org\/10.1111\/acel.14103","journal-title":"Aging Cell"},{"key":"6241_CR32","doi-asserted-by":"publisher","first-page":"15741","DOI":"10.1007\/s12035-025-05208-6","volume":"62","author":"MJ Basellini","year":"2025","unstructured":"Basellini MJ, Granadino-Rold\u00e1n JM, Torres-Ortega PV et al (2025) Oleuropein aglycone, an olive polyphenol, influences alpha-synuclein aggregation and exerts neuroprotective effects in different Parkinson\u2019s disease models. Mol Neurobiol 62:15741\u201315758. https:\/\/doi.org\/10.1007\/s12035-025-05208-6","journal-title":"Mol Neurobiol"},{"key":"6241_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108597","volume":"186","author":"N Chatterjee","year":"2024","unstructured":"Chatterjee N, Gonz\u00e1lez-Durruthy M, Costa MD et al (2024) Differential impact of diesel exhaust particles on glutamatergic and dopaminergic neurons in Caenorhabditis elegans: a neurodegenerative perspective. Environ Int 186:108597. https:\/\/doi.org\/10.1016\/j.envint.2024.108597","journal-title":"Environ Int"},{"key":"6241_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1559151","author":"AK Torres","year":"2025","unstructured":"Torres AK, Mira RG, Pinto C, Inestrosa NC (2025) Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunities. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2025.1559151","journal-title":"Front Cell Neurosci"},{"key":"6241_CR35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/ijms25010443","volume":"25","author":"Y Wu","year":"2023","unstructured":"Wu Y, Chen Y, Yu X et al (2023) Towards understanding neurodegenerative diseases: insights from Caenorhabditis elegans. IJMS 25:443. https:\/\/doi.org\/10.3390\/ijms25010443","journal-title":"IJMS"},{"key":"6241_CR36","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.4103\/1673-5374.371345","volume":"18","author":"A Bigi","year":"2023","unstructured":"Bigi A, Cascella R, Cecchi C (2023) \u03b1-Synuclein oligomers and fibrils: partners in crime in synucleinopathies. Neural Regen Res 18:2332\u20132342. https:\/\/doi.org\/10.4103\/1673-5374.371345","journal-title":"Neural Regen Res"},{"key":"6241_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/toxsci\/kfab011","volume":"180","author":"JM Bradner","year":"2021","unstructured":"Bradner JM, Kalia V, Lau FK et al (2021) Genetic or toxicant-induced disruption of vesicular monoamine storage and global metabolic profiling in Caenorhabditis elegans. Toxicol Sci 180:313\u2013324. https:\/\/doi.org\/10.1093\/toxsci\/kfab011","journal-title":"Toxicol Sci"},{"key":"6241_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000440845","volume":"16","author":"DK Gupta","year":"2016","unstructured":"Gupta DK, Hang X, Liu R et al (2016) Levodopa-induced motor and dopamine receptor changes in Caenorhabditis elegans overexpressing human alpha-synuclein. Neurodegener Dis 16:179\u2013183. https:\/\/doi.org\/10.1159\/000440845","journal-title":"Neurodegener Dis"},{"key":"6241_CR39","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1212\/WNL.50.5.1323","volume":"50","author":"LV Metman","year":"1998","unstructured":"Metman LV, Del Dotto P, van den Munckhof P et al (1998) Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson\u2019s disease. Neurology 50:1323\u20131326. https:\/\/doi.org\/10.1212\/WNL.50.5.1323","journal-title":"Neurology"},{"key":"6241_CR40","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.3390\/cells11233736","volume":"11","author":"DK Kwon","year":"2022","unstructured":"Kwon DK, Kwatra M, Wang J, Ko HS (2022) Levodopa-induced dyskinesia in Parkinson\u2019s disease: pathogenesis and emerging treatment strategies. Cells 11:3736. https:\/\/doi.org\/10.3390\/cells11233736","journal-title":"Cells"},{"key":"6241_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/nu10091139","volume":"10","author":"SL Johnson","year":"2018","unstructured":"Johnson SL, Park HY, DaSilva NA et al (2018) Levodopa-reduced mucuna pruriens seed extract shows neuroprotective effects against Parkinson\u2019s disease in murine microglia and human neuroblastoma cells, Caenorhabditis elegans, and Drosophila melanogaster. Nutrients 10:1139. https:\/\/doi.org\/10.3390\/nu10091139","journal-title":"Nutrients"},{"key":"6241_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26164843","volume":"26","author":"P Chalorak","year":"2021","unstructured":"Chalorak P, Sanguanphun T, Limboonreung T, Meemon K (2021) Neurorescue effects of frondoside A and ginsenoside Rg3 in C. elegans model of Parkinson\u2019s disease. Molecules 26:4843. https:\/\/doi.org\/10.3390\/molecules26164843","journal-title":"Molecules"},{"key":"6241_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113893","volume":"21","author":"G Di Rosa","year":"2020","unstructured":"Di Rosa G, Brunetti G, Scuto M et al (2020) Healthspan enhancement by olive polyphenols in C. elegans wild type and Parkinson\u2019s models. IJMS 21:3893. https:\/\/doi.org\/10.3390\/ijms21113893","journal-title":"IJMS"},{"key":"6241_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110610","volume":"382","author":"WG Salgueiro","year":"2023","unstructured":"Salgueiro WG, Soares MV, Martins CF et al (2023) Dopaminergic modulation by quercetin: in silico and in vivo evidence using Caenorhabditis elegans as a model. Chem Biol Interact 382:110610. https:\/\/doi.org\/10.1016\/j.cbi.2023.110610","journal-title":"Chem Biol Interact"},{"key":"6241_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11071378","volume":"11","author":"SS Das","year":"2022","unstructured":"Das SS, Sarkar A, Chabattula SC et al (2022) Food-grade quercetin-loaded nanoemulsion ameliorates effects associated with Parkinson\u2019s disease and cancer: studies employing a transgenic C. elegans model and human cancer cell lines. Antioxidants 11:1378. https:\/\/doi.org\/10.3390\/antiox11071378","journal-title":"Antioxidants"},{"key":"6241_CR46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1523\/JNEUROSCI.19-01-00072.1999","volume":"19","author":"JS Duerr","year":"1999","unstructured":"Duerr JS, Frisby DL, Gaskin J et al (1999) The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors. J Neurosci 19:72\u201384. https:\/\/doi.org\/10.1523\/JNEUROSCI.19-01-00072.1999","journal-title":"J Neurosci"},{"key":"6241_CR47","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Parkinson disease Nat Rev Dis Primers"},{"key":"6241_CR48","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/520640","volume":"2011","author":"V Mu\u00f1oz-Soriano","year":"2011","unstructured":"Mu\u00f1oz-Soriano V, Paricio N (2011) Drosophila models of Parkinson\u2019s disease: discovering relevant pathways and novel therapeutic strategies. Parkinson\u2019s Disease 2011:520640. https:\/\/doi.org\/10.4061\/2011\/520640","journal-title":"Parkinson\u2019s Disease"},{"key":"6241_CR49","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1089\/ars.2023.0247","volume":"40","author":"E Proshkina","year":"2024","unstructured":"Proshkina E, Koval L, Platonova E et al (2024) Polyphenols as potential geroprotectors. Antioxid Redox Signal 40:564\u2013593. https:\/\/doi.org\/10.1089\/ars.2023.0247","journal-title":"Antioxid Redox Signal"},{"key":"6241_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.665031","volume":"12","author":"MdS Islam","year":"2021","unstructured":"Islam MdS, Quispe C, Hossain R et al (2021) Neuropharmacological effects of quercetin: a literature-based review. Front Pharmacol 12:665031. https:\/\/doi.org\/10.3389\/fphar.2021.665031","journal-title":"Front Pharmacol"},{"key":"6241_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/nu17172884","volume":"17","author":"A Lehoczki","year":"2025","unstructured":"Lehoczki A, Fekete M, Jarecsny T et al (2025) The neuroprotective role of curcumin: from molecular pathways to clinical translation\u2014a narrative review. Nutrients 17:2884. https:\/\/doi.org\/10.3390\/nu17172884","journal-title":"Nutrients"},{"key":"6241_CR52","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nchembio791","volume":"2","author":"D Kokel","year":"2006","unstructured":"Kokel D, Li Y, Qin J, Xue D (2006) The nongenotoxic carcinogens naphthalene and para-dichlorobenzene suppress apoptosis in Caenorhabditis elegans. Nat Chem Biol 2:338\u2013345. https:\/\/doi.org\/10.1038\/nchembio791","journal-title":"Nat Chem Biol"},{"key":"6241_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glae196","volume":"79","author":"A Zhang","year":"2024","unstructured":"Zhang A, Meecham-Garcia G, Nguyen Hong C et al (2024) Characterization of effects of mTOR inhibitors on aging in Caenorhabditis elegans. J Gerontol A Biol Sci Med Sci 79:glae196. https:\/\/doi.org\/10.1093\/gerona\/glae196","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"6241_CR54","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1007\/s13346-024-01770-z","volume":"15","author":"G Sharma","year":"2025","unstructured":"Sharma G, Wadhwa K, Kumar S et al (2025) Revolutionizing Parkinson\u2019s treatment: harnessing the potential of intranasal nanoemulsions for targeted therapy. Drug Deliv Transl Res 15:2589\u20132607. https:\/\/doi.org\/10.1007\/s13346-024-01770-z","journal-title":"Drug Deliv Transl Res"},{"key":"6241_CR55","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades N, Cohen SIA, Deas E et al (2012) Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein. Cell 149:1048\u20131059. https:\/\/doi.org\/10.1016\/j.cell.2012.03.037","journal-title":"Cell"},{"key":"6241_CR56","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1042\/BST20250489","volume":"54","author":"AK Buell","year":"2026","unstructured":"Buell AK (2026) The amplification of \u03b1-synuclein amyloid fibrils. Biochem Soc Trans 54:427\u2013435. https:\/\/doi.org\/10.1042\/BST20250489","journal-title":"Biochem Soc Trans"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06241-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06241-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06241-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:02:49Z","timestamp":1790452969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06241-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6241"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06241-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"21 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors; ethical approval was therefore not required.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This article is a review of previously published studies and contains no data from individual human participants.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All schematic figures in this article (Figs.\u00a0\n                      \n                      ,\n                      \n                      ,\n                      \n                      ,\n                      \n                      ,\n                      \n                      ,\n                      \n                      ) are original works created by the authors and were not reproduced or adapted from any previously published source. Individual graphical elements were generated using a generative AI image tool (ChatGPT), arranged in Microsoft PowerPoint, and assembled into the final composites in Microsoft Paint. Figure\u00a0\n                      \n                      and Table\u00a0\n                      \n                      were prepared by the authors without the use of generative AI. The authors reviewed and verified all figures for scientific accuracy and take full responsibility for their content.","order":4,"name":"Ethics","label":"Use of AI and \u0130mage-Creation Tools","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"928"}}